Press release
mRNA Therapeutics CDMO Global Market Insights: Growth Drivers, Size & Forecasts to 2029
mRNA Therapeutics CDMO Market Size
What Is the Forecasted Market Growth Rate of the mRNA Therapeutics CDMO Industry?
The market size for mRNA therapeutics CDMO has seen swift expansion over the past years. It's projected to rise from $4.24 billion in 2024 to $4.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.0%. The escalation in the historic period is due to factors such as the surging demand for quick vaccine development, amplified public and private investment in mRNA research, increasing occurrence of infectious diseases, broadening practices of pharmaceutical outsourcing, and a growing international emphasis on preparing for pandemics.
How Will the mRNA Therapeutics CDMO Market Size Evolve From 2025 to 2029?
In the coming years, a fast-paced expansion is projected for the mRNA therapeutics CDMO market, with an anticipated size of $7.40 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. Multiple factors contributing to this projected growth during the forecast period include an escalated interest in personalized medicine, an increased demand for quick response systems against new diseases, growing healthcare spending in emerging regions, expanded government support for local manufacturing, and surging interest towards non-infectious disease applications. Notable trends expected during the forecast period are the development of lipid nanoparticle delivery technologies, enhanced automation in manufacturing procedures, broader acceptance of modular and continuous manufacturing platforms, betterment of cold chain logistics infrastructure, and a rising implementation of artificial intelligence for process optimization.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-cdmo-global-market-report
What Are the Main Growth Drivers in the mRNA Therapeutics CDMO Market Today?
The escalating prevalence of chronic and infectious diseases is predicted to fuel the expansion of the mRNA therapeutics CDMO market. This includes persistent health issues such as diabetes, heart diseases, and asthma, as well as diseases brought on by harmful microorganisms, such as viruses, bacteria, and parasites, which can be directly or indirectly transmitted between individuals. The increase in such diseases can be attributed to aging populations, which are more prone to long-lasting illnesses and infections. mRNA therapeutics CDMO contributes to the combat against these diseases by offering comprehensive development and manufacturing services that speed up the provision of specific, personalized mRNA treatments to patients. For example, in April 2024, according to Allergy UK, a UK-based national charity, over 21 million people in the UK were affected by allergies, which had become the most frequently reported long-term health issue in 2022, with predictions suggesting that by 2026, half of Europe's population will suffer from at least one allergy. Therefore, the rising prevalence of chronic and infectious diseases is stimulating the expansion of the mRNA therapeutics CDMO market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25841&type=smp
Which mRNA Therapeutics CDMO Market Segment Is Expected to Lead Through 2029?
The mrna therapeutics cdmo market covered in this report is segmented -
1) By Type Of Service: Development Services, Manufacturing Services, Laboratory Services
2) By Indication: Infectious Diseases, Metabolic And Genetic Diseases, Cardiovascular And Cerebrovascular Diseases
3) By Application: Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations
Subsegments:
1) By Development Services: Process Development, Analytical Method Development, Formulation Development, Regulatory Support
2) By Manufacturing Services: Plasmid DNA Manufacturing, mRNA Synthesis, Lipid Nanoparticle (LNP) Formulation, Fill-Finish Services
3) By Laboratory Services: Quality Control Testing, Stability Testing, Bioanalytical Testing, Preclinical Testing
Which Market Trends Are Expected to Dominate mRNA Therapeutics CDMO Industry Growth?
Top businesses in the mRNA therapeutics CDMO market are making strides in developing innovative solutions, such as in situ nanomedicine vaccines. They aim to improve the precision and efficiency of mRNA-based vaccines through targeted immune stimulation. An in situ nanomedicine vaccine is an advanced mRNA-based therapy developed to generate nanomedicines within the patient's body. This allows for targeted delivery and personalized immune activation through engineered transgene expression. For example, in January 2025, Esphera SynBio Inc., a biotechnology company from Canada, announced a new initiative backed by the CQDM Quantum Leap program. The project is designed to evolve first-generation lipid nanoparticle or messenger RNA (LNP/mRNA) vaccines with the inclusion of exclusive transgene designs. These designs trigger in vivo production of immunostimulatory nanomedicines, enabling precise antigen delivery and tailored immune responses. This positions the technology as a potential game-changer in vaccine technology innovation.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25841&type=smp
Which Companies Hold the Largest Market Share in the mRNA Therapeutics CDMO Sector?
Major companies operating in the mrna therapeutics cdmo market are Sanofi SA, Thermo Fisher Scientific Inc., Boehringer Ingelheim, Danaher Corporation, Merck KGaA, FUJIFILM Holdings Corporation, Evonik Industries AG, BioNTech SE, AGC Biologics GmbH, Eurofins Scientific SA, Samsung Biologics Co. Ltd., Wuxi Biologics, Recipharm AB, EMERGENT BioSolutions Inc., Genscript Biotech, Novo Holdings AS, Ginkgo Bioworks Holdings Inc., Corden Pharma Corp., CureVac SE, TriLink BioTechnologies LLC, Biocina Pty Ltd., Aldevron LLC, Synbio Technologies LLC, etherna manufacturing, Bio-Synthesis Inc., Biomay AG, RiboPro
Where Is the mRNA Therapeutics CDMO Market Experiencing the Highest Growth?
North America was the largest region in the mRNA therapeutics CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna therapeutics cdmo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Therapeutics CDMO Global Market Insights: Growth Drivers, Size & Forecasts to 2029 here
News-ID: 4157559 • Views: …
More Releases from The Business Research Company
Viral Diagnostic Test Kits Market Insights Highlight Segment Expansion And Marke …
The viral diagnostic test kits market is gaining significant traction as the world focuses more on pandemic preparedness and rapid disease detection. Innovations in testing technology and a rising need for decentralized healthcare solutions are driving this sector forward. Let's explore the market size, key players, emerging trends, and segment details shaping the future of viral diagnostic testing.
Projected Market Growth for Viral Diagnostic Test Kits
The viral diagnostic test…
Vertebroplasty Needles Market Report Evaluates Growth Drivers, Challenges And Ma …
The vertebroplasty needles market is set for remarkable growth as demand for spine-related procedures rises globally. With advancements in surgical techniques and a growing elderly population, this sector is poised to expand significantly in the coming years. Let's explore the expected market size, key drivers, leading players, and segmentation details that define this evolving landscape.
Projected Market Size Growth for Vertebroplasty Needles by 2030
The vertebroplasty needles market is anticipated…
Ventricular Assist Device Market Report Provides Insights Into Market Evolution …
The ventricular assist device market is gaining significant traction as advancements in cardiovascular technology continue to evolve. Driven by demographic changes and innovations in device design, this sector is set to experience substantial growth and transformation over the coming years. Let's explore the current market size, key players, emerging trends, and detailed segment analysis that define this dynamic industry.
Projected Market Size and Growth of the Ventricular Assist Device Market …
Vein Illumination Devices Market Research Explores Growth Within A $1.05 Billion …
The vein illumination devices market is poised for remarkable expansion as advancements in medical imaging technology continue to enhance patient care. With a growing focus on non-invasive procedures and improved accuracy in intravenous access, this sector is attracting significant attention from healthcare providers and technology developers alike. Below, we explore the market's valuation, key players, segmentation, and the main drivers behind its growth.
Projected Market Value and Growth of the Vein…
More Releases for RNA
Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
